CIK 0001811063 · Non-accelerated filer<br>Smaller reporting company
Nuvation Bio Inc.
Sign in to watch- Ticker
- NUVB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850862255
- Phone
- 332-208-6102
- Business address
- 1 PENNSYLVANIA PLAZA, SUITE 3805, NEW YORK, NY, 10019
- Former names
- Panacea Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $709,240
- in 1 filing, $709K under 10b5-1 plans
Net −$709,240. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-10 | NODELMAN OLEG Director | Grant or award · Warrant (Right to Buy) | +130,000 | 130,000 | ||
| 2021-02-10 | NODELMAN OLEG Director | Grant or award · Warrant (Right to Buy) | +702,000 | 702,000 | ||
| 2021-02-10 | NODELMAN OLEG Director | Grant or award · Warrant (Right to Buy) | +131,333 | 131,333 | ||
| 2021-02-10 | Omega Fund V, L.P. 10% owner | Conversion | +8,130,097 | 27,712,373 | ||
| 2021-02-10 | Omega Fund V, L.P. 10% owner | Grant or award | +500,000 | $10.00 | $5.0M | 28,212,373 |
| 2021-02-10 | Omega Fund V, L.P. 10% owner | Conversion · Series A Preferred Stock | −8,130,097 | 0 | ||
| 2021-02-10 | VERNON W ANTHONY Director | Grant or award · Stock Option (Right to Buy) | +51,703 | 51,703 | ||
| 2021-02-10 | VERNON W ANTHONY Director | Grant or award · Stock Option (Right to Buy) | +187,658 | 187,658 | ||
| 2021-02-10 | FALBERG KATHRYN E Director | Grant or award · Stock Option (Right to Buy) | +239,361 | 239,361 | ||
| 2021-02-10 | BLICKENSTAFF KIM D Director | Grant or award · Stock Option (Right to Buy) | +51,703 | 51,703 | ||
| 2021-02-10 | BLICKENSTAFF KIM D Director | Grant or award · Stock Option (Right to Buy) | +187,658 | 187,658 | ||
| 2021-02-10 | Bazemore Robert B Director | Grant or award · Stock Option (Right to Buy) | +51,703 | 51,703 | ||
| 2021-02-10 | Bazemore Robert B Director | Grant or award · Stock Option (Right to Buy) | +187,658 | 187,658 | ||
| 2021-02-10 | WELCH DANIEL G Director | Grant or award · Stock Option (Right to Buy) | +86,184 | 86,184 | ||
| 2021-02-10 | WELCH DANIEL G Director | Grant or award · Stock Option (Right to Buy) | +312,750 | 312,750 | ||
| 2021-02-10 | Markel Stacy SVP, Human Resources | Grant or award · Stock Option (Right to Buy) | +398,935 | 398,935 | ||
| 2021-02-10 | Markel Stacy SVP, Human Resources | Grant or award · Stock Option (Right to Buy) | +254,810 | 254,810 | ||
| 2021-02-10 | Templeman Thomas SVP, Pharmaceutical Ops | Grant or award · Stock Option (Right to Buy) | +398,935 | 398,935 | ||
| 2021-02-10 | Templeman Thomas SVP, Pharmaceutical Ops | Grant or award · Stock Option (Right to Buy) | +398,935 | 398,935 | ||
| 2021-02-10 | Hattersley Gary Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +398,935 | 398,935 |
Page 14 of 15 · 291 trades